AEF vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AEF exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an extremely attractive valuation, trading at a P/E of 3.84. The stock is significantly undervalued relative to its Graham Number ($19.83) and Intrinsic Value ($67.56), suggesting a massive margin of safety. Despite a bearish technical trend score in the baseline, actual price performance is explosive with a 96.9% 1-year return. The combination of low debt, high ROE (31.21%), and a sustainable 8.07% dividend yield makes this a compelling value play.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
AEF vs BRK-B: Head-to-Head Comparison
This page compares abrdn Emerging Markets ex-China Fund, Inc. (AEF) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.